The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Trends in Solubility of Polymorphs
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amidon, G. L., Lennernäs, H., Shah, V. P., & Crison, J. R. (1995) · Pharmaceutical Research · doi:10.1023/a:1016212804288 · Cited by 5,430
What is the True Solubility Advantage for Amorphous Pharmaceuticals?
Hancock, B. C., & Parks, M. (2000) · Pharmaceutical Research · doi:10.1023/a:1007516718048 · Cited by 1,358
Polymorphism in Pharmaceutical Solids
(2018) · CRC Press eBooks · doi:10.3109/9781420073225 · Cited by 1,099
Solid state chemistry of drugs
Byrn, S. R. (1982) · Medical Entomology and Zoology · Cited by 1,086
Ritonavir: An Extraordinary Example of Conformational Polymorphism
Bauer, J., Spanton, S., Henry, R., Quick, J., Dziki, W., Porter, W., & Morris, J. (2001) · Pharmaceutical Research · doi:10.1023/a:1011052932607 · Cited by 1,071
Polymorphism in pharmaceutical solids
Giordano, F. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00252-8 · Cited by 671
Solubility and Solubilization in Aqueous Media
Yalkowsky, S. H. (1999) · Cited by 669
Pharmaceutical Solids: A Strategic Approach to Regulatory Considerations
Byrn, S. R., Pfeiffer, R. R., Ganey, M. E., Hoiberg, C. P., & Poochikian, G. (1995) · Pharmaceutical Research · doi:10.1023/a:1016241927429 · Cited by 476
Thermodynamic Driving Force in Nucleation and Growth Processes
Hoffman, J. D. (1958) · The Journal of Chemical Physics · doi:10.1063/1.1744688 · Cited by 439
Dissolution Behavior of Crystalline Solvated and Nonsolvated Forms of Some Pharmaceuticals
Shefter, E., & Higuchi, T. (1963) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600520815 · Cited by 373
Effect of polymorphism on the absorption of chloramphenicol from chloramphenicol palmitate
Aguiar, A. J., Krc, J., Kinkel, A. W., & Samyn, J. C. (1967) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600560712 · Cited by 307
Dissolution Behavior of Polymorphs of Chloramphenicol Palmitate and Mefenamic Acid
Aguiar, A. J., & Zelmer, J. E. (1969) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600580817 · Cited by 170
Scientific Considerations of Pharmaceutical Solid Polymorphism in Abbreviated New Drug Applications
Yu, L. X., Furness, M. S., Raw, A., Outlaw, K. P. W., Nashed, N. E., Ramos, E., Miller, S. P. F., Adams, R. C., Fang, F., Patel, R. M., et al. (2003) · Pharmaceutical Research · doi:10.1023/a:1023285627778 · Cited by 126
Characterization of Two Polymorphs of Salmeterol Xinafoate Crystallized From Supercritical Fluids
Tong, H. H. Y., Shekunov, B. Y., York, P., & Chow, A. H. L. (2001) · Pharmaceutical Research · doi:10.1023/a:1011000915769 · Cited by 89
Preparation and Characterization of Ranitidine-HC1 Crystals
Madan, T., & Kakkar, A. P. (1994) · Drug Development and Industrial Pharmacy · doi:10.3109/03639049409050198 · Cited by 36
Solid State Characterization of Dehydroepiandrosterone
Chang, L., Caira, M. R., & Guillory, J. K. (1995) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600841007 · Cited by 26
Cited by
Strategies to Address Low Drug Solubility in Discovery and Development
Williams, H. D., Trevaskis, N. L., Charman, S. A., Shanker, R. M., Charman, W. N., Pouton, C. W., & Porter, C. J. H. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.005660 · Cited by 1,570
Kawabata, Y., Wada, K., Nakatani, M., Yamada, S., & Onoue, S. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.08.032 · Cited by 1,181
Solubility Advantage of Amorphous Drugs and Pharmaceutical Cocrystals
Babu, N. J., & Nangia, A. (2011) · Crystal Growth & Design · doi:10.1021/cg200492w · Cited by 1,004
Pharmaceutical cocrystals: along the path to improved medicines
Duggirala, N. K., Perry, M. L., Almarsson, Ö., & Zaworotko, M. J. (2016) · Chemical Communications · doi:10.1039/c5cc08216a · Cited by 928
Solubility Advantage of Pharmaceutical Cocrystals
Good, D. J., & Rodríguez-Hornedo, N. (2009) · Crystal Growth & Design · doi:10.1021/cg801039j · Cited by 841
Metadata
- Authors
- Pudipeddi, M., & Serajuddin, A. T. M.
- Venue
- Journal of Pharmaceutical Sciences
- Publisher
- Elsevier BV
- Published
- 2005-05
- Volume
- 94
- Issue
- 5
- Pages
- 929-939
- ISSN
- 0022-3549 (ISSN-L)
- OpenAlex
- W2101212670
- Cited by
- 505
- References
- 16
- FWCI
- 9.27
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.